Lipidor AB (publ), at its Annual General Meeting on 11 June 2020, adopted an instruction regarding the appointment of the Nomination Committee. As of 30 September 2020, the three largest shareholders were Cerbios-Pharma SA, Råsunda Förvaltning AB and Aurena Laboratories AB. All have accepted the nomination. The nomination committee comprises the following members: Anton van Troostenburg, appointed by Cerbios-Pharma SA; Per Nilsson, appointed by Råsunda Förvaltning AB; Magnus Hedman, appointed by Aurena Laboratories AB; Fredrik Sjövall, Chairman of the Board, convener.